These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31782618)

  • 1. From Patient to Molecule: In Pursuit of Universal Treatments for TB.
    Heaton PM; Barrett JS
    Clin Transl Sci; 2020 Mar; 13(2):224-227. PubMed ID: 31782618
    [No Abstract]   [Full Text] [Related]  

  • 2. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine.
    Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N
    Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texas tuberculosis research symposium 2018: Research and clinical collaboration within the State of Texas - Moving towards elimination of TB.
    Dhandayuthapani S; Actor JK; Graviss EA
    Tuberculosis (Edinb); 2019 May; 116S():S1. PubMed ID: 31126719
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis vaccine types and timings.
    Orme IM
    Clin Vaccine Immunol; 2015 Mar; 22(3):249-57. PubMed ID: 25540272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.
    Zhang N; Strydom N; Tyagi S; Soni H; Tasneen R; Nuermberger EL; Savic RM
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic effects of Mycobacterium tuberculosis rv3407 DNA vaccine in mice.
    Liang Y; Zhao Y; Bai X; Xiao L; Yang Y; Zhang J; Wang L; Cui L; Wang T; Shi Y; Zhao W; Wu X
    Autoimmunity; 2018 Dec; 51(8):417-422. PubMed ID: 30632804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Human Primate Models of Tuberculosis.
    Peña JC; Ho WZ
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the past, a long way to future challenges for a greater control of tuberculosis.
    Villa S; Riccardi N; Canetti D; Alagna R; Castellotti P; Ferrarese M; Cirillo D; Barberis I; Bragazzi NL; Gazzaniga V; Ricucci V; Codecasa LR; Besozzi G; Martini M
    Tuberculosis (Edinb); 2020 Jul; 123():101948. PubMed ID: 32741532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
    Sacchettini JC; Rubin EJ; Freundlich JS
    Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A courageous step down the road toward a new tuberculosis vaccine.
    Dockrell HM; Zhang Y
    Am J Respir Crit Care Med; 2009 Apr; 179(8):628-9. PubMed ID: 19351870
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic study of Mycobacterium tuberculosis and its clinical applications.
    Tyagi JS; Sharma D
    Indian J Pediatr; 2002 Nov; 69 Suppl 1():S29-38. PubMed ID: 12501923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DNA vaccines encoding M. Tb gene Bfrb and Mpt32 in mice model.
    Shahzad MI; Shahid N; Sial N; Hasanat A; Khalid M; Yousaf M; Hyder Z; Ashfaq M; Rivera G; Khanum A
    Pak J Pharm Sci; 2017 Sep; 30(5(Supplementary)):2025-2029. PubMed ID: 29105639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of vaccine research and development: tuberculosis.
    Girard MP; Fruth U; Kieny MP
    Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation.
    Afkhami S; Lai R; D'agostino MR; Vaseghi-Shanjani M; Zganiacz A; Yao Y; Jeyanathan M; Xing Z
    J Infect Dis; 2019 Sep; 220(8):1355-1366. PubMed ID: 31198944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.
    Dover LG; Bhatt A; Bhowruth V; Willcox BE; Besra GS
    Expert Rev Vaccines; 2008 May; 7(4):481-97. PubMed ID: 18444894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
    Marimani M; Ahmad A; Duse A
    Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The search for better vaccines against TB.
    Bloom BR
    BMJ; 2020 Jan; 368():m92. PubMed ID: 31941658
    [No Abstract]   [Full Text] [Related]  

  • 20. Animal Models of Tuberculosis: An Overview.
    Williams A; Orme IM
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.